India’s indigenous coronavirus vaccine ‘Covaxin’ shows robust immune response in 1st phase clinical trials
First Published: 17th December, 2020 18:25 IST
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first phase trials of the vaccine
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials.
A detailed immunogenicity response of the first phase trials of the vaccine has been declared by the manufacturers. Covaxin, jointly developed by Hyderabad-based Bharat Biotech and ICMR has been found to be safe generating no serious adverse effects in people of all dose groups as per the results of the first phase clinical trials.
ICMR has informed that the vaccine can be stored at 2 to 8 degree Celcius temperatures which also makes it compatible with the National Immunization plan.
Covaxin is one among the three coronavirus vaccine candidates being considered for emergency use authorisation in India by the Drug regulator. It is currently in its third and last phase of clinical trials with nearly 26 thousand volunteers in the age group of 18 and 55.
(with inputs from News on Air)
COMMENTS
TOPMOST STORY NOW
Live 5 Guwahati Schools to Face Action After Pass Percentage Drops to Below 25% in HSLC Exams 2025
11th April 2025
Live Sikkim Shocker: 13-year-old Sexually Assaulted Multiple Times by Multiple People since 2024
11th April 2025
Live Bundles of Joy: Aizawl Woman Gives Birth to Healthy Triplet
11th April 2025
Live Mizoram: Universal Health Care Scheme Benefits 131 in First Week, Private Hospitals Sector Opts Out of Scheme
11th April 2025
WE RECOMMEND
Assam CM Sarma Lauds Scrapping of Bangladesh Transhipment, Calls It a Big Boost for NE Security
He also described the decision as a reflection of the government’s commitment to protect the country’s “strategic and economic priorities”.
11th April 2025
Inside ‘Operation Rana’ – A High-Stakes, Top-Secret Extradition Mission
To ensure Rana's safety--and prevent any self-harm--one NIA official reportedly held his hand throughout the journey
11th April 2025
Who is Tahawwur Rana, Key Accused in 26/11 Mumbai Attacks, Extradited from the US Today?
Tahawwur Rana's extradition was confirmed in February this year when US President Donald Trump announced he would be handed over to India.
10th April 2025
NIA arrests 26/11 Mumbai terror attacks accused Tahawwur Rana on arrival at Delhi airport
NIA had secured Tahawwur Rana's extradition following years of sustained and concerted efforts
10th April 2025
Will ensure judicial integrity: NDBA’s statement before Tahawwur Rana’s trial
Tahawwur Rana is being brought to India for trial after the US Supreme Court rejected his plea to stay his extradition, exhausting all judicial options.
10th April 2025